Health Care/Hospital

GMAX Zhengzhou Manufacturing Site Breaks Ground

HANGZHOU, China, Dec. 15, 2020 /PRNewswire/ -- Gmax Biopharm today holds ground-breaking ceremony for itsZhengzhou, China manufacturing site which is the production base for its GMA102 (T2D), GMA105 (obesity), and GMA301A/B (PAH for adult and children) drugs to be launched between 2023-2025, upon...

2020-12-15 18:00 1324

IP Key South-East Asia urges consumers to be aware of counterfeit cosmetics and beauty products

BANGKOK, Dec. 15, 2020 /PRNewswire/ -- Today, the IP Key South-East Asia (SEA) project, funded by the European Union (EU), is launching the second phase of the #YourHealthIsPriceless campaign to promote consumer awareness against counterfeit cosmetics and personal care products, including beauty ...

2020-12-15 17:34 2264

GenScript and InnoBation Enter into the Agreement for CAR-T therapy

NANJING, China and SEOUL, South Korea, Dec. 15, 2020 /PRNewswire/ -- A global leading biotech company GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) announces that it has reached the agreement for cell line development and engineering, manufacture service of GMP Plasmids and Len...

2020-12-15 15:18 5569

HistoIndex and Consortium Partners Awarded S$1.2M for the Development of AI-based Diagnostics Tool in the Identification of High-Risk Nonalcoholic Fatty Liver Disease Population

* HistoIndex joins forces with a consortium of partners from NHS Health Boards, UK universities and technology companies for the development of a novel AI-based integrated diagnostic tool. * There is currently no available method to accurately identify patients with NAFLD who are at a highe...

2020-12-15 12:00 865

Guardant Health AMEA Wins Frost & Sullivan's Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa

MUMBAI, India, Dec. 15, 2020 /PRNewswire/ -- Guardant Health Asia, Middle East andAfrica (AMEA) has won Frost & Sullivan's 2020 Market Leadership Award for Liquid Biopsy in Precision Oncology in AMEA. This accolade is a testament to the success of the company's flagship liquid biopsy, the Guardan...

2020-12-15 11:00 1603

Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials

CAMBRIDGE, Mass., SUZHOU, China, UTRECHT, Netherlands, Dec. 15, 2020 /PRNewswire/ -- Harbour BioMed (HBM)(HKEX:02142), andUtrecht University (UU) today announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the prevention and treatment o...

2020-12-15 08:00 7834

Hyundai Motor's Mini '45' EV Puts Emotions in Motion

SEOUL, South Korea, Dec. 15, 2020 /PRNewswire/ -- Hyundai Motor Company unveiled details of its one-of-a-kind mini EV based on the '45' concept car in a short film on YouTube. The 6-minute video shows how the minicar uses Emotion Adaptive Vehicle Control (EAVC) technology to support young patient...

2020-12-15 07:30 17256

Otto Damsma Joins Bioforum as Vice President of Asia Pacific Operations

Bioforum Bolsters Leadership Team to Drive Expansion in Australia and Asia Pacific Region NESS ZIONA, Israel, Dec. 15, 2020 /PRNewswire/ -- Bioforum , a global data-focused contract research organization (CRO), today announced the appointment ofOtto Damsma as Vice Pr...

2020-12-15 05:00 1846

Regent Pacific Completes Acquisition of Deep Longevity, Inc

* Expands into the emerging field of artificial intelligence (AI) and longevity medicine * Strengthens shareholder mix by adding experienced longevity and wellness biotechnology investors and entrepreneurs HONG KONG, Dec. 15, 2020 /PRNewswire/ --Regent Pacific Group Limited ("Regent Pacific" ...

2020-12-15 02:03 14120

Ruben S. Martin III Elected Chairman Of Mercy Ships International's Board Of Directors

Highly Accomplished Business Leader and Philanthropist has been a Long-Time Board Member and Supporter of Mercy Ships and its Work to Bring Hope and Healing to the World's Most Disadvantaged Peoples GARDEN VALLEY, Texas, Dec. 14, 2020 /PRNewswire/ -- Mercy Ships, the global healthcare charity th...

2020-12-14 23:00 3466

Mercy Ships Announces Retirement Of Board Chairman Myron Ullman, Who Has Been Instrumental In Achieving Its Mission Of Bringing Hope And Healing To The World's Most Disadvantaged Peoples

Since he became Chairman in 2001, Mercy Ships has seen exceptional growth including reaching the milestone of performing more than 100,000 surgical procedures on board its charity hospital ships, attracting 20,000 volunteers from 60 nations, and providing healthcare services and materials worth m...

2020-12-14 23:00 1454

Ruben S. Martin III Elected Chairman Of Mercy Ships International's Board Of Directors

Highly Accomplished Business Leader and Philanthropist has been a Long-Time Board Member and Supporter of Mercy Ships and its Work to Bring Hope and Healing to the World's Most Disadvantaged Peoples GARDEN VALLEY, Texas, Dec. 14, 2020 /PRNewswire/ -- Mercy Ships, the global healthcare charity th...

2020-12-14 23:00 3490

CipherHealth Recognized with Enabling Technology Leadership Award by Frost & Sullivan for its Patient Engagement Platform

The CipherHealth platform supports patient engagement through the entire continuum of care to deliver superior operational efficiency, improved outcomes and bottom-line growth SANTA CLARA, Calif., Dec. 14, 2020 /PRNewswire/ -- Based on its recent analysis of the North American patient engagement...

2020-12-14 23:00 1764

Mercy Ships Announces Retirement Of Board Chairman Myron Ullman, Who Has Been Instrumental In Achieving Its Mission Of Bringing Hope And Healing To The World's Most Disadvantaged Peoples

Since he became Chairman in 2001, Mercy Ships has seen exceptional growth including reaching the milestone of performing more than 100,000 surgical procedures on board its charity hospital ships, attracting 20,000 volunteers from 60 nations, and providing healthcare services and materials worth m...

2020-12-14 23:00 1441

Sunshine Guojian Selects Verseau's VSIG4-targeted Antibody as the Second Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- 3SBio Inc. ("3SBio")'s subsidiary, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. ("Sunshine Guojian") and Verseau Therapeutics, Inc.  ("Verseau") today announced the selection of a monoclonal antibody targeting VSIG4, as a ...

2020-12-14 22:28 1957

I-Mab Added to Nasdaq Biotechnology Index

SHANGHAI and GAITHERSBURG, Md., Dec. 14, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab's American Depositary Shares (ADS) have been ...

2020-12-14 21:00 8858

Regent Pacific's Commercial Strategic Partner Receives Approval from Taiwan Food and Drug Administration

HONG KONG, Dec. 14, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Orient EuroPharma Co., L...

2020-12-14 20:20 4029

Canadian pilot study suggests prescription icosapent ethyl (VASCEPA®) might improve symptoms of COVID-19 and reduce inflammation

TORONTO, ON, Dec. 14, 2020 /PRNewswire/ -- The results of a Canadian study released this weekend provides encouraging data suggesting that the prescription strength omega-3 called icosapent ethyl (VASCEPA) may reduce inflammation and improve symptoms in patients with a diagnosis of COVID-19. "Th...

2020-12-14 20:00 2143

Sai Life Sciences releases its first Sustainability Report

- Developed as per the Global Reporting Initiative (GRI) standards - Highlights the various sustainable choices embraced by the company in steering its journey on a sustainable path HYDERABAD, India, Dec. 14, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Resear...

2020-12-14 18:42 2313

Hummingbird Bioscience Announces Collaboration with Tempus to Harness AI-driven Precision Medicine to Accelerate Clinical Development of HMBD-001 In HER3 Driven Cancers

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing revolutionary therapies for hard-to-drug targets, today announced a collaboration with Tempus, a leader in artificial intelligence and precision medicine, to drive t...

2020-12-14 18:00 1691
1 ... 701702703704705706707 ... 858